vs
Side-by-side financial comparison of Cytek Biosciences, Inc. (CTKB) and EQUITY BANCSHARES INC (EQBK). Click either name above to swap in a different company.
EQUITY BANCSHARES INC is the larger business by last-quarter revenue ($63.5M vs $62.1M, roughly 1.0× Cytek Biosciences, Inc.). EQUITY BANCSHARES INC runs the higher net margin — 34.8% vs -70.9%, a 105.7% gap on every dollar of revenue. On growth, EQUITY BANCSHARES INC posted the faster year-over-year revenue change (28.4% vs 8.1%). EQUITY BANCSHARES INC produced more free cash flow last quarter ($38.1M vs $-1.8M). Over the past eight quarters, Cytek Biosciences, Inc.'s revenue compounded faster (17.7% CAGR vs 6.6%).
Cytek Biosciences, Inc. develops, manufactures and sells high-performance flow cytometry systems, associated reagents and analysis software. Its solutions serve life science research, clinical diagnostics and biopharmaceutical sectors, with a global customer base across North America, Europe and the Asia-Pacific region.
Prosperity Bancshares, Inc. is a bank holding company headquartered in Houston, Texas with operations in Texas and central Oklahoma. As of December 31, 2019, the company operated 285 branches: 65 in the Houston area, including The Woodlands, Texas; 30 in South Texas, including Corpus Christi, Texas and Victoria, Texas; 75 in the Dallas–Fort Worth metroplex; 22 in East Texas; 29 in Central Texas, including Austin, Texas and San Antonio; 34 in West Texas, including Lubbock, Texas, Midland–Odess...
CTKB vs EQBK — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $62.1M | $63.5M |
| Net Profit | $-44.1M | $22.1M |
| Gross Margin | 52.9% | — |
| Operating Margin | -9.0% | 41.7% |
| Net Margin | -70.9% | 34.8% |
| Revenue YoY | 8.1% | 28.4% |
| Net Profit YoY | -557.1% | 30.0% |
| EPS (diluted) | — | $1.07 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $62.1M | $63.5M | ||
| Q3 25 | $52.3M | $18.0M | ||
| Q2 25 | $45.6M | $58.4M | ||
| Q1 25 | $41.5M | $60.6M | ||
| Q4 24 | $57.5M | $58.3M | ||
| Q3 24 | $51.5M | $55.3M | ||
| Q2 24 | $46.6M | $55.4M | ||
| Q1 24 | $44.9M | $55.9M |
| Q4 25 | $-44.1M | $22.1M | ||
| Q3 25 | $-5.5M | $-29.7M | ||
| Q2 25 | $-5.6M | $15.3M | ||
| Q1 25 | $-11.4M | $15.0M | ||
| Q4 24 | $9.6M | $17.0M | ||
| Q3 24 | $941.0K | $19.9M | ||
| Q2 24 | $-10.4M | $11.7M | ||
| Q1 24 | $-6.2M | $14.1M |
| Q4 25 | 52.9% | — | ||
| Q3 25 | 52.7% | — | ||
| Q2 25 | 52.3% | — | ||
| Q1 25 | 48.6% | — | ||
| Q4 24 | 58.5% | — | ||
| Q3 24 | 56.3% | — | ||
| Q2 24 | 54.6% | — | ||
| Q1 24 | 51.3% | — |
| Q4 25 | -9.0% | 41.7% | ||
| Q3 25 | -17.6% | -207.2% | ||
| Q2 25 | -23.3% | 31.5% | ||
| Q1 25 | -36.1% | 31.1% | ||
| Q4 24 | 5.2% | 35.0% | ||
| Q3 24 | -8.2% | 43.1% | ||
| Q2 24 | -18.3% | 29.4% | ||
| Q1 24 | -23.9% | 31.8% |
| Q4 25 | -70.9% | 34.8% | ||
| Q3 25 | -10.5% | -164.7% | ||
| Q2 25 | -12.2% | 26.1% | ||
| Q1 25 | -27.5% | 24.8% | ||
| Q4 24 | 16.8% | 29.1% | ||
| Q3 24 | 1.8% | 35.9% | ||
| Q2 24 | -22.4% | 21.1% | ||
| Q1 24 | -13.8% | 25.2% |
| Q4 25 | — | $1.07 | ||
| Q3 25 | — | $-1.55 | ||
| Q2 25 | — | $0.86 | ||
| Q1 25 | — | $0.85 | ||
| Q4 24 | — | $1.06 | ||
| Q3 24 | — | $1.28 | ||
| Q2 24 | — | $0.76 | ||
| Q1 24 | — | $0.90 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $90.9M | — |
| Total DebtLower is stronger | — | $443.2M |
| Stockholders' EquityBook value | $341.7M | $732.1M |
| Total Assets | $461.5M | $6.4B |
| Debt / EquityLower = less leverage | — | 0.61× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $90.9M | — | ||
| Q3 25 | $93.3M | — | ||
| Q2 25 | $75.5M | — | ||
| Q1 25 | $95.3M | — | ||
| Q4 24 | $98.7M | — | ||
| Q3 24 | $162.3M | — | ||
| Q2 24 | $177.9M | — | ||
| Q1 24 | $168.8M | — |
| Q4 25 | — | $443.2M | ||
| Q3 25 | — | $486.9M | ||
| Q2 25 | — | $448.4M | ||
| Q1 25 | — | $376.9M | ||
| Q4 24 | — | $312.8M | ||
| Q3 24 | — | $437.5M | ||
| Q2 24 | — | $391.7M | ||
| Q1 24 | — | $367.1M |
| Q4 25 | $341.7M | $732.1M | ||
| Q3 25 | $378.6M | $711.9M | ||
| Q2 25 | $377.6M | $635.6M | ||
| Q1 25 | $379.6M | $617.3M | ||
| Q4 24 | $395.7M | $592.9M | ||
| Q3 24 | $385.5M | $504.0M | ||
| Q2 24 | $389.1M | $461.4M | ||
| Q1 24 | $392.6M | $456.8M |
| Q4 25 | $461.5M | $6.4B | ||
| Q3 25 | $494.9M | $6.4B | ||
| Q2 25 | $493.3M | $5.4B | ||
| Q1 25 | $482.6M | $5.4B | ||
| Q4 24 | $499.5M | $5.3B | ||
| Q3 24 | $491.2M | $5.4B | ||
| Q2 24 | $483.7M | $5.2B | ||
| Q1 24 | $492.1M | $5.2B |
| Q4 25 | — | 0.61× | ||
| Q3 25 | — | 0.68× | ||
| Q2 25 | — | 0.71× | ||
| Q1 25 | — | 0.61× | ||
| Q4 24 | — | 0.53× | ||
| Q3 24 | — | 0.87× | ||
| Q2 24 | — | 0.85× | ||
| Q1 24 | — | 0.80× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-771.0K | $51.4M |
| Free Cash FlowOCF − Capex | $-1.8M | $38.1M |
| FCF MarginFCF / Revenue | -2.9% | 60.0% |
| Capex IntensityCapex / Revenue | 1.6% | 20.9% |
| Cash ConversionOCF / Net Profit | — | 2.33× |
| TTM Free Cash FlowTrailing 4 quarters | $-8.8M | $88.8M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-771.0K | $51.4M | ||
| Q3 25 | $-3.9M | $8.5M | ||
| Q2 25 | $108.0K | $28.3M | ||
| Q1 25 | $-125.0K | $21.7M | ||
| Q4 24 | $2.0M | $73.8M | ||
| Q3 24 | $13.2M | $23.5M | ||
| Q2 24 | $6.2M | $16.0M | ||
| Q1 24 | $4.0M | $12.6M |
| Q4 25 | $-1.8M | $38.1M | ||
| Q3 25 | $-4.6M | $4.5M | ||
| Q2 25 | $-1.5M | $26.0M | ||
| Q1 25 | $-974.0K | $20.2M | ||
| Q4 24 | $1.1M | $65.4M | ||
| Q3 24 | $12.2M | $19.7M | ||
| Q2 24 | $5.2M | $15.2M | ||
| Q1 24 | $3.4M | $10.6M |
| Q4 25 | -2.9% | 60.0% | ||
| Q3 25 | -8.7% | 24.7% | ||
| Q2 25 | -3.2% | 44.5% | ||
| Q1 25 | -2.3% | 33.3% | ||
| Q4 24 | 1.9% | 112.1% | ||
| Q3 24 | 23.7% | 35.6% | ||
| Q2 24 | 11.0% | 27.4% | ||
| Q1 24 | 7.6% | 19.0% |
| Q4 25 | 1.6% | 20.9% | ||
| Q3 25 | 1.3% | 22.3% | ||
| Q2 25 | 3.5% | 3.9% | ||
| Q1 25 | 2.0% | 2.4% | ||
| Q4 24 | 1.6% | 14.6% | ||
| Q3 24 | 2.0% | 6.8% | ||
| Q2 24 | 2.3% | 1.5% | ||
| Q1 24 | 1.3% | 3.6% |
| Q4 25 | — | 2.33× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | 1.85× | ||
| Q1 25 | — | 1.44× | ||
| Q4 24 | 0.21× | 4.35× | ||
| Q3 24 | 14.05× | 1.18× | ||
| Q2 24 | — | 1.37× | ||
| Q1 24 | — | 0.90× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CTKB
| Products | $46.6M | 75% |
| Services | $15.5M | 25% |
EQBK
Segment breakdown not available.
